Establishment of Hybridoma Department considers as a prominent step toward scientific development of the country; since it is mainly aims to centralize and coordinate research activities related to producing monoclonal antibodies.  Providing research centers with the needed monoclonal antibodies in laboratorial and semi-industrial levels, besides, their quantification for using in kits and biological products will definitely help the national projects to achieve their goals.

The significant importance of monoclonal antibodies in diagnostic and therapeutic purposes and the other hand to huge amount of money devoted to provide them annually on, justifies the establishment of this research center from the economical aspect.

In a short period of time, several kinds of antibodies including mAbs against sperm surface antigens, anti-ferritin, PSA, Inhibin, lung cancer and about 100 various peptides as tumor markers have been produced.

Filed of Activity:

1. Producing of monoclonal antibodies in laboratorial and semi-industrial levels required for research and therapeutic centers in the country
2. Generating of antibody against human and animal biomakers
3. Generating of antibody against tumor markers
4. Generating of antibody against different proteins
5. Generating of antibody against chemical substances, drugs, biochemical metabolites and environmental toxins
6. Providing the possibility of different types of cell culture / cell preservation
7. Performing different tests e.g. ELISA and assessment the efficacy of generated monoclonal antibodies
8. Collaborating in policy making and determination of research priorities concerning mAbs in the country
9. Meeting educational and research demands of the country with regard to mAbs
10. Training researchers in high tech areas of biotechnology
11. Establishing efficient ties with international institutes with the aim of transferring technology through holding educational courses, workshops as well as conducting research projects and theses